FARS2 Mutations: More Than Two Phenotypes? A Case Report
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media S.A.
Abstract
FARS2, a nuclear gene, encodes the mitochondrial phenylalanyl-tRNA synthetase (mtPheRS). Previous reports have described two distinct phenotypes linked to FARS2 gene mutation: an early onset epileptic encephalopathy and spastic paraplegia. This report describes a distinctive phenotype of FARS2-linked, juvenile onset refractory epilepsy, caused by a hemizygous mutation in a compound heterozygous state (p.V197M and exon 2 microdeletion). A 17-year- old woman with normal development presented with a super refractory focal motor status epilepticus. Only an emergency life-saving surgery aborted her status after all therapeutic interventions, including anesthesia, failed to control her seizures. Pathological and biochemical activities on muscle biopsy showed mitochondrial proliferation with enhanced isolated activities of complexes II and IV, suggestive of a compensatory mechanism for the bioenergetic deficiency. Postoperatively, the patient started experiencing focal aware motor seizures originating from the contralateral hemisphere after being seizure free for a few months. This report suggests a third phenotypic manifestation of FARS2 gene mutation. © Copyright © 2020 Hotait, Nasreddine, El-Khoury, Dirani, Nawfal and Beydoun.
Description
Keywords
Fars2, Juvenile onset epilepsy, Mitochondrial epilepsy, Mitochondrial trna synthetase, Refractory status epilepticus, Alanine aminotransferase, Amino acid transfer rna ligase, Cytochrome c oxidase, Lactate dehydrogenase, Mitochondrial dna, Transfer rna, Adolescent, Article, Blood cell count, Brain analysis, Case report, Cerebrospinal fluid, Cerebrospinal fluid analysis, Clinical article, Computer assisted tomography, Copy number variation, Electroencephalogram, Electroencephalography, Fars2 gene, Female, Gene, Gene mutation, Genetic analysis, Histopathology, Hospitalization, Human, Leukocyte count, Nerve cell differentiation, Neuropsychological test, Nuclear magnetic resonance imaging, Phenotype, Polymerase chain reaction, Risk factor, Sanger sequencing, Spastic paraplegia, Whole exome sequencing